- Home
- PHGE vs CNEY Comparison
PHGE vs CNEY Comparison
Compare PHGE & CNEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- CNEY
- Stock Information
- Founded
- PHGE 2015
- CNEY 2018
- Country
- PHGE Israel
- CNEY China
- Employees
- PHGE N/A
- CNEY N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- CNEY Major Chemicals
- Sector
- PHGE Health Care
- CNEY Industrials
- Exchange
- PHGE Nasdaq
- CNEY Nasdaq
- Market Cap
- PHGE 12.6M
- CNEY 12.4M
- IPO Year
- PHGE N/A
- CNEY 2021
- Fundamental
- Price
- PHGE $0.55
- CNEY $2.23
- Analyst Decision
- PHGE Strong Buy
- CNEY
- Analyst Count
- PHGE 1
- CNEY 0
- Target Price
- PHGE $15.00
- CNEY N/A
- AVG Volume (30 Days)
- PHGE 292.1K
- CNEY 386.2K
- Earning Date
- PHGE 11-13-2025
- CNEY 01-01-0001
- Dividend Yield
- PHGE N/A
- CNEY N/A
- EPS Growth
- PHGE N/A
- CNEY N/A
- EPS
- PHGE N/A
- CNEY N/A
- Revenue
- PHGE N/A
- CNEY $36,049,275.00
- Revenue This Year
- PHGE N/A
- CNEY N/A
- Revenue Next Year
- PHGE N/A
- CNEY N/A
- P/E Ratio
- PHGE N/A
- CNEY N/A
- Revenue Growth
- PHGE N/A
- CNEY N/A
- 52 Week Low
- PHGE $0.34
- CNEY $1.56
- 52 Week High
- PHGE $1.16
- CNEY $21.61
- Technical
- Relative Strength Index (RSI)
- PHGE 56.74
- CNEY 43.69
- Support Level
- PHGE $0.50
- CNEY $2.18
- Resistance Level
- PHGE $0.54
- CNEY $2.95
- Average True Range (ATR)
- PHGE 0.03
- CNEY 0.19
- MACD
- PHGE 0.00
- CNEY -0.02
- Stochastic Oscillator
- PHGE 71.42
- CNEY 10.84
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).
About CNEY CN Energy Group Inc.
CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.